Search research articles
Contact Us
Filters
Showing results (51-60 of 355) with videos related to
Page
of 36
Sort By:
Neuropharmacology
|
March 4, 2000
Distinct influence of the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine [(R,S)-PPG] on different forms of neuronal damage
P Henrich-Noack, P J Flor, C F Sabelhaus, et al.
Behavioural Brain Research
|
December 12, 2012
Significant increase in anxiety during aging in mGlu5 receptor knockout mice
D Inta, M A Vogt, A Luoni, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
May 12, 2001
Discovery and characterization of non-competitive antagonists of group I metabotropic glutamate receptors
F Gasparini, P Floersheim, P J Flor, et al.
Amino Acids
|
October 10, 2002
In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article
R Kuhn, A Pagano, N Stoehr, et al.
Journal of Medicinal Chemistry
|
November 23, 2000
Chiral resolution, pharmacological characterization, and receptor docking of the noncompetitive mGlu1 receptor antagonist (+/-)-2-hydroxyimino- 1a, 2-dihydro-1H-7-oxacyclopropa[b]naphthalene-7a-carboxylic acid ethyl ester
D Ott, P Floersheim, W Inderbitzin, et al.
Annals of the New York Academy of Sciences
|
December 20, 2003
Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats
P J Kenny, N E Paterson, B Boutrel, et al.
The European Journal of Neuroscience
|
May 1, 2001
An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors
V Bruno, G Battaglia, A Copani, et al.
Neuropharmacology
|
October 24, 2003
(-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection
M Maj, V Bruno, Z Dragic, et al.
Journal of Internal Medicine
|
June 2, 2026
Brain pathology in relation to somatic diseases: Exploring the body-brain crosstalk
G Grande, M Valletta, F Gasparini, et al.
Neurobiology of Disease
|
January 7, 2015
Fragile X mice have robust mGluR5-dependent alterations of social behaviour in the Automated Tube Test
C E F de Esch, W E van den Berg, R A M Buijsen, et al.
Page
of 36
Search research articles
Search
Showing results (51-60 of 355) with videos related to
Sort By:
Page
of 36
Neuropharmacology
|
March 4, 2000
Distinct influence of the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine [(R,S)-PPG] on different forms of neuronal damage
P Henrich-Noack, P J Flor, C F Sabelhaus, et al.
Behavioural Brain Research
|
December 12, 2012
Significant increase in anxiety during aging in mGlu5 receptor knockout mice
D Inta, M A Vogt, A Luoni, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
May 12, 2001
Discovery and characterization of non-competitive antagonists of group I metabotropic glutamate receptors
F Gasparini, P Floersheim, P J Flor, et al.
Amino Acids
|
October 10, 2002
In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article
R Kuhn, A Pagano, N Stoehr, et al.
Journal of Medicinal Chemistry
|
November 23, 2000
Chiral resolution, pharmacological characterization, and receptor docking of the noncompetitive mGlu1 receptor antagonist (+/-)-2-hydroxyimino- 1a, 2-dihydro-1H-7-oxacyclopropa[b]naphthalene-7a-carboxylic acid ethyl ester
D Ott, P Floersheim, W Inderbitzin, et al.
Annals of the New York Academy of Sciences
|
December 20, 2003
Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats
P J Kenny, N E Paterson, B Boutrel, et al.
The European Journal of Neuroscience
|
May 1, 2001
An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors
V Bruno, G Battaglia, A Copani, et al.
Neuropharmacology
|
October 24, 2003
(-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection
M Maj, V Bruno, Z Dragic, et al.
Journal of Internal Medicine
|
June 2, 2026
Brain pathology in relation to somatic diseases: Exploring the body-brain crosstalk
G Grande, M Valletta, F Gasparini, et al.
Neurobiology of Disease
|
January 7, 2015
Fragile X mice have robust mGluR5-dependent alterations of social behaviour in the Automated Tube Test
C E F de Esch, W E van den Berg, R A M Buijsen, et al.
Page
of 36